Published September 19, 2019 | Version v1
Conference paper Open

A Hierarchical Attention Network-Based Approach for Depression Detection from Transcribed Clinical Interviews. Proc. Interspeech 2019

Description

The high prevalence of depression in society has given rise to a need for new digital tools that can aid its early detection. Among other effects, depression impacts the use of language. Seeking to exploit this, this work focuses on the detection of depressed and non-depressed individuals through the analysis of linguistic information extracted from transcripts of clinical interviews with a virtual agent. Specifically, we investigated the advantages of employing hierarchical attention-based networks for this task. Using Global Vectors (GloVe) pretrained word embedding models to extract low-level representations of the words, we compared hierarchical local-global attention networks and hierarchical contextual attention networks. We performed our experiments on the Distress Analysis Interview Corpus - Wizard of Oz (DAIC-WoZ) dataset, which contains audio, visual, and linguistic information acquired from participants during a clinical session. Our results using the DAIC-WoZ test set indicate that hierarchical contextual attention networks are the most suitable configuration to detect depression from transcripts. The configuration achieves an Unweighted Average Recall (UAR) of .66 using the test set, surpassing our baseline, a Recurrent Neural Network that does not use attention.

Notes

Funding by EU- sustAGE (826506), EU-RADAR-CNS (115902), Key Program of the Natural Science Foundation of Tianjin, CHINA (18JCZDJC36300) and BMW Group Research Pages 221-225 https://www.isca-speech.org/archive/Interspeech_2019/index.html

Files

sustAGE-UAU-12.pdf

Files (287.2 kB)

Name Size Download all
md5:770a9b7632d687f1cc07419a01b2ee9f
287.2 kB Preview Download

Additional details

Funding

sustAGE – Smart environments for person-centered sustainable work and well-being 826506
European Commission
RADAR-CNS – Remote Assessment of Disease and Relapse in Central Nervous System Disorders 115902
European Commission